Carotid Intima Media Thickness, Inflammatory Markers, and Endothelial Activation Markers in HIV Patients with Lipoatrophy Increased at 48 Weeks Regardless of Use of Rosiglitazone or Placebo

Risk for Opportunistic Disease and Death after Reinitiating Continuous Antiretroviral Therapy in Patients with HIV Previously Receiving Episodic Therapy

(2013)   ANNALS OF INTERNAL MEDICINE

Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis

(2010) Antonio Diez-Ruiz et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

(2009) Philip D Home et al.   LANCET

Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin

(2009) Colin R. Dormuth et al.   PLoS One

Endothelial Activation Markers Are Linked to HIV Status and Are Independent of Antiretroviral Therapy and Lipoatrophy

(2008) Allison C Ross et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Endothelial Function in Human Immunodeficiency Virus-Infected Antiretroviral-Naive Subjects Before and After Starting Potent Antiretroviral Therapy

(2008) Francesca J. Torriani et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY